CHICAGO, Sept. 06, 2017 -- Typenex Medical, an industry leader in medical devices and supplies, announced today it is bringing Rad-Control, a new irradiation indicator tag technology, to blood banks and blood centers in the United States and Canada. Typenex Medical has exclusively partnered with a European market leader, On Point Indicators GmbH, to offer the product to its customers. The product technology confirms blood irradiation by visual verification, minimizes current documentation practices and increases efficiency for healthcare staff.
“The irradiation indicator tag market has not seen innovation within the last decade. We are excited to launch Rad-Control, and breathe some life into this market,” said John Fife, owner, and chief executive officer (CEO), Typenex Medical. “With increasing pressures on healthcare facilities to do more with less, we are positioned to help improve workflows while providing compelling value.”
Rad-Control is used in hospitals and blood centers to ensure the blood component has been exposed to irradiation. The specially-formulated indicator technology in the tag changes color after exposure, acting as a visual verification. This practice has been common in ensuring blood components are irradiated, confirming that components have received irradiation, and helping to prevent multiple irradiation cycles. Properly irradiating blood helps to prevent life threatening Transfusion-Associated Graft-vs.-Host Disease (TA-GvHD).
Current practices are built around irradiation tags that must be stored in a refrigerated environment. Rad-Control can be stored at room temperature, eliminating repetitive trips from the irradiator to the refrigerated storage location. Additionally, many facilities document the irradiation tag-lot number and expiration information by hand in their logbook. The Rad-Control irradiation indicator tag features an easy peel off label that, instead, can be placed directly into the logbook – saving time and ensuring accuracy.
“On one hand, it is easier to store the tags near the machine, and on the other, it is easier to accurately document the use of the product,” said Brad Palmer, Director of New Product Development, Typenex Medical. “The biggest feedback we hear from our customers is that our irradiation indicator tag allows for better workflows. With our strong reputation in blood banks around the country, we are excited to bring superior solutions to the market that can help meet customer needs.”
Typenex Medical has been a leading blood bank and laboratory supplier for more than 10 years. The company maintains a considerable market share in the medical device and supply industry, and is continuing to expand to other areas of the hospital – including the operating room.
About Typenex Medical, LLC
Typenex® Medical is a medical device and supply company founded by entrepreneur and investor, John Fife. The Typenex Medical advantage is connecting with customers to understand their process needs, then delivering simple, high-quality products that streamline workflows. Thinking about patient safety and comfort is a strength, along with efficiency and cost-effectiveness – all while providing a quality product. For more information please visit www.typenexmedical.com.
Contact: Amanda Jaron Product Manager – Blood Bank and Lab 312-888-4097 [email protected]


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



